Clayton Medical Research

St Louis, Missouri 63117

0 studies enrolling now · 15 studies all time

What they study most

Albuminuria, Arthritis, Psoriatic, Diabetes Mellitus, Type 2, Diabetic Nephropathy, Herpes Labialis, Lupus Erythematosus, Systemic, Osteoarthritis, Hip, Osteoarthritis, Knee, Psoriatic Arthritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Type 1 Diabetes

Studies at this site

• Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid Arthritis — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis — Completed
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections — Stopped early
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis — Completed
• A Study of LY3337641 in Rheumatoid Arthritis — Stopped early
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) — Completed
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus — Stopped early
• A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX — Completed
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes — Completed
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy — Completed